Search hospitals
>
Ohio
>
Dayton
Kettering Medical Center
Claim this profile
Dayton, Ohio 45429
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Pancreatic Cancer
512 reported clinical trials
8 medical researchers
Summary
Kettering Medical Center is a medical facility located in Dayton, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Pancreatic Cancer and other specialties. Kettering Medical Center is involved with conducting 512 clinical trials across 526 conditions. There are 8 research doctors associated with this hospital, such as Howard M. Gross, Thomas Reid, MD, Mark Hoeprich, MD, and Brian Schwartz, MD.
Area of expertise
Breast Cancer
Kettering Medical Center has run 90 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Kettering Medical Center has run 69 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Howard M. Gross
Kettering Medical Center
7 years of reported clinical research
Thomas Reid, MD
Memorial Hospital of South Bend
3 years of reported clinical research
Mark Hoeprich, MD
Kettering Health
3 years of reported clinical research
Brian Schwartz, MD
Kettering Medical Center
3 years of reported clinical research
Clinical Trials running at Kettering Medical Center
Lung Cancer
Breast Cancer
Bladder Cancer
Ovarian Cancer
Breast cancer
Cancer
Prostate Cancer
Kidney Cancer
Esophageal cancer
Melanoma
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kettering Medical Center?
Kettering Medical Center is a medical facility located in Dayton, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Pancreatic Cancer and other specialties. Kettering Medical Center is involved with conducting 512 clinical trials across 526 conditions. There are 8 research doctors associated with this hospital, such as Howard M. Gross, Thomas Reid, MD, Mark Hoeprich, MD, and Brian Schwartz, MD.
Where is Kettering Medical Center located?
Kettering Medical Center is located at 3535 Southern Blvd, Kettering, OH 45429.
Who should I call to ask about financial aid or insurance network?
**Kettering Medical Center Financial and Insurance Assistance** - For financial assistance, contact our financial counselors at **(937) 395-8659** or visit us. - For insurance inquiries, please call **(937) 395-8880**.
What insurance does Kettering Medical Center accept?
Kettering Health Network, including Kettering Medical Center, accepts a variety of insurance plans such as commercial, Medicare Advantage, and managed Medicaid plans. The network has contracts with major insurers including Aetna, Anthem Blue Cross and Blue Shield, CIGNA, Medical Mutual of Ohio, and United HealthCare, ensuring in-network care availability. It's important to verify participation with your specific insurance plan and product, as it may vary.
What awards or recognition has Kettering Medical Center received?
Kettering Medical Center, situated in Dayton, Ohio, is a key component of the Kettering Health network and collaborates closely with Memorial Sloan Kettering Cancer Center (MSK), an NCI-Designated Comprehensive Cancer Center. This collaboration enhances Kettering Medical Center's access to MSK's research, clinical trials, and advanced cancer treatments. Additionally, the center is noted for its innovative research, clinical trials in cancer care and diagnostics, and the utilization of sophisticated technology like the on-site cyclotron for producing radiotracers for cancer diagnosis.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.